Credit: Kent Vliet

Komodo dragon blood vs superbugs

Embargoed until: Publicly released:

It may sound like something from Game of Thrones, but harnessing the blood of dragons to beat deadly diseases could soon become reality, according to US scientists. They found new compounds in the blood of Komodo dragons that help prevent the lizards falling prey to the 57 species of bacteria in their saliva, and which could potentially be used to develop new drugs to fight antibiotic-resistant diseases. Of the 48 compounds - called cationic antimicrobial peptides (CAMPs) - they extracted from the blood, seven were effective in fighting Pseudomonas aeruginosa and Staphylococcus aureus - a pair of nasty disease-causing bacteria - while an eighth CAMP was effective against P. aeruginosa, they say.

Journal/conference: Journal of Proteome Research

Organisation/s: George Mason University, USA

Funder: The Defense Threat Reduction Agency.

Media Release

From: American Chemical Society

Antimicrobial substances identified in Komodo dragon blood

In a land where survival is precarious, Komodo dragons thrive despite being exposed to scads of bacteria that would kill less hardy creatures. Now in a study published in the Journal of Proteome Research, scientists report that they have detected antimicrobial protein fragments in the lizard's blood that appear to help them resist deadly infections. The discovery could lead to the development of new drugs capable of combating bacteria that have become resistant to antibiotics.

The world's largest lizard, Komodo dragons live on five small islands in Indonesia. The saliva of these creatures contains at least 57 species of bacteria, which are believed to contribute to the demise of their prey. Yet, the Komodo dragon appears resistant to these bacteria, and serum from these animals has been shown to have antibacterial activity. Substances known as cationic antimicrobial peptides (CAMPs) are produced by nearly all living creatures and are an essential part of the innate immune system. So, Barney Bishop, Monique van Hoek and colleagues at the College of Science at George Mason University wondered whether they could isolate CAMPs from Komodo dragon blood, as they previously had done with alligator blood to expand the library of known CAMPs for therapeutic studies.

The team used an approach known as bioprospecting. They incubated Komodo dragon blood with negatively charged hydrogel particles that they developed to capture the peptides, which are positively charged. With this method, they identified and sequenced 48 potential CAMPs with mass spectrometry. All but one of these was derived from histone proteins, which are known to have antimicrobial activities. Eight were synthesized and tested against Pseudomonas aeruginosa and Staphylococcus aureus. Seven of the peptides showed significant potency against both bacteria. The eighth was only effective against P. aeruginosa. The researchers conclude that Komodo dragon blood plasma contains a host of potentially viable antimicrobial peptides that could help lead to new therapeutics.


News for:


Media contact details for this story are only visible to registered journalists.